Matrix-M™ adjuvant: enhancing immune responses by 'setting the stage' for the antigen

被引:34
作者
Bengtsson, Karin Lovgren [1 ]
Karlsson, Karin H. [1 ]
Magnusson, Sofia E. [1 ]
Reimer, Jenny M. [1 ]
Stertman, Linda [1 ]
机构
[1] Isconova AB, SE-75318 Uppsala, Sweden
关键词
adjuvant; Matrix-M; mode-of-action; vaccine; VACCINE; FORMULATION; INDUCTION; ISCOMS; CELLS;
D O I
10.1586/14760584.2013.814822
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
引用
收藏
页码:821 / 823
页数:3
相关论文
共 19 条
[1]
SYNTEX ADJUVANT FORMULATION [J].
ALLISON, AC ;
BYARS, NE .
RESEARCH IN IMMUNOLOGY, 1992, 143 (05) :519-525
[2]
Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]
[3]
EFFECTS OF ANTIGEN ON MIGRATION OF RECIRCULATING LYMPHOCYTES THROUGH SINGLE LYMPH-NODES [J].
CAHILL, RNP ;
FROST, H ;
TRNKA, Z .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (04) :870-888
[4]
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial [J].
Cox, Rebecca J. ;
Pedersen, Gabriel ;
Madhun, Abdullah S. ;
Svindland, Signe ;
Saevik, Marianne ;
Breakwell, Lucy ;
Hoschler, Katja ;
Willemsen, Marieke ;
Campitelli, Laura ;
Nostbakken, Jane Kristin ;
Weverling, Gerrit Jan ;
Klap, Jaco ;
McCullough, Kenneth C. ;
Zambon, Maria ;
Kompier, Ronald ;
Sjursen, Haakon .
VACCINE, 2011, 29 (45) :8049-8059
[5]
LOVGREN K, 1988, BIOTECHNOL APPL BIOC, V10, P161
[6]
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice [J].
Magnusson, Sofia E. ;
Reimer, Jenny M. ;
Karlsson, Karin H. ;
Lilja, Lena ;
Bengtsson, Karin Lovgren ;
Stertman, Linda .
VACCINE, 2013, 31 (13) :1725-1733
[7]
ISCOM, A NOVEL STRUCTURE FOR ANTIGENIC PRESENTATION OF MEMBRANE-PROTEINS FROM ENVELOPED VIRUSES [J].
MOREIN, B ;
SUNDQUIST, B ;
HOGLUND, S ;
DALSGAARD, K ;
OSTERHAUS, A .
NATURE, 1984, 308 (5958) :457-460
[8]
Functional aspects of iscoms [J].
Morein, B ;
Bengtsson, KL .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (04) :295-299
[9]
MOREIN B, 1996, CONCEPTS VACCINE DEV, P243
[10]
Neeland MR, 2013, VET IMMUNOL IMMUNOPA